These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31297886)

  • 1. miR-153-3p regulates progression of ovarian carcinoma in vitro and in vivo by targeting MCL1 gene.
    Li C; Zhang Y; Zhao W; Cui S; Song Y
    J Cell Biochem; 2019 Nov; 120(11):19147-19158. PubMed ID: 31297886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
    Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-1-3p inhibits the growth and metastasis of ovarian cancer cells by targeting DYNLT3.
    Zhu FJ; Li JZ; Wang LL
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8713-8721. PubMed ID: 32964959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00152 down-regulated
    Huang Y; Luo H; Li F; Yang Y; Ou G; Ye X; Li N
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29339419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCL1 regulates cell death, tumor growth and chemosensitivity to sabutoclax in ovarian adenocarcinoma.
    Li C; Song Y; Li P
    Cell Tissue Res; 2020 Mar; 379(3):625-633. PubMed ID: 31754782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA SNHG20 promotes ovarian cancer development by targeting microRNA-338-3p to regulate MCL1 expression.
    Wang D; Li Z; Li H; Lu J; Qin Q
    Oncol Lett; 2021 Feb; 21(2):130. PubMed ID: 33552251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-302a-3p Promotes Radiotherapy Sensitivity of Hepatocellular Carcinoma by Regulating Cell Cycle via MCL1.
    Yang Z; Zhang M; Zhang J; Chu C; Hu B; Huang L
    Comput Math Methods Med; 2022; 2022():1450098. PubMed ID: 36262872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA TRPM2-AS promotes ovarian cancer progression and cisplatin resistance by sponging miR-138-5p to release SDC3 mRNA.
    Ding Y; Tan X; Abasi A; Dai Y; Wu R; Zhang T; Li K; Yan M; Huang X
    Aging (Albany NY); 2021 Feb; 13(5):6832-6848. PubMed ID: 33621194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
    Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-509-3p enhances platinum drug sensitivity in ovarian cancer.
    Niu L; Ni H; Hou Y; Du Q; Li H
    Gene; 2019 Feb; 686():63-67. PubMed ID: 30408550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene.
    Li Y; Zhou J; Wang J; Chen X; Zhu Y; Chen Y
    Biol Res; 2020 Mar; 53(1):10. PubMed ID: 32156314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
    Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
    Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
    Gong YB; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-126-3p inhibits ovarian cancer proliferation and invasion via targeting PLXNB2.
    Xiang G; Cheng Y
    Reprod Biol; 2018 Sep; 18(3):218-224. PubMed ID: 30054097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
    Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
    IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2.
    Duan S; Dong X; Hai J; Jiang J; Wang W; Yang J; Zhang W; Chen C
    Biomed Pharmacother; 2018 Nov; 107():712-720. PubMed ID: 30138893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.